Natco Pharma has informed about a Press Release dated January 02, 2017 titled ‘NATCO launches VELPANAT in Nepal- 1st generic version of Sofosbuvir 400mg/Velpatasvir 100mg fixed dose combination medicine in the country’.
The above information is a part of company’s filings submitted to BSE.